MAIA•benzinga•
MAIA Biotechnology Announces USAN Approval Of Ateganosine As Generic Name For Lead Molecule THIO, A Telomere-Targeting Anticancer Agent For Advanced NSCLC Treatment In FDA Process
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 19, 2025 by benzinga